- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
SMS Pharmaceuticals Limited — Updates, 02-05-2025: Press Release
02-05-2025 | 11:43 am
02-05-2025 | 11:43 am
SMS Pharmaceuticals has announced a board meeting during which it revealed WHO Geneva prequalification approval for its Visakhapatnam manufacturing facility. This certification enhances SMS Pharma’s global regulatory standing, boosting its capacity to supply Anti-Retroviral (ARV) APIs internationally. The approval strengthens the company’s reputation for quality and improves its competitiveness in the global pharmaceutical API market.
No comments yet. Be the first to comment!